Retour
38
Fourchette du Jour
1,19 €
1,45 €
Fourchette 52 Semaines
1,19 €
1,45 €
Volume
1
Moyenne 50J / 200J
1,45 €
/
1,32 €
Clôture Précédente
1,45 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 6,1 | 0,4 |
| P/B | 0,4 | 2,9 |
| ROE % | 6,9 | 3,7 |
| Net Margin % | 8,2 | 3,8 |
| Rev Growth 5Y % | 10,7 | 10,0 |
| D/E | 0,6 | 0,2 |
Points Clés
Revenue grew 10,66% annually over 5 years — strong growth
Earnings declined -21,10% over the past year
Generating 1,60B in free cash flow
P/E of 6,11 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,31%
Croissance
Revenue Growth (5Y)
10,66%
Revenue (1Y)5,35%
Earnings (1Y)-21,10%
FCF Growth (3Y)-6,09%
Qualité
Return on Equity
6,94%
ROIC5,22%
Net Margin8,16%
Op. Margin12,93%
Sécurité
Debt / Equity
0,58
Current Ratio0,58
Interest Coverage3,13
Valorisation
P/E Ratio
6,11
P/B Ratio0,42
EV/EBITDA8,63
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,35% | Revenue Growth (3Y) | 10,77% |
| Earnings Growth (1Y) | -21,10% | Earnings Growth (3Y) | -15,73% |
| Revenue Growth (5Y) | 10,66% | Earnings Growth (5Y) | 3,00% |
| Profitability | |||
| Revenue (TTM) | 25,69B | Net Income (TTM) | 2,10B |
| ROE | 6,94% | ROA | 3,65% |
| Gross Margin | 25,74% | Operating Margin | 12,93% |
| Net Margin | 8,16% | Free Cash Flow (TTM) | 1,60B |
| ROIC | 5,22% | FCF Growth (3Y) | -6,09% |
| Safety | |||
| Debt / Equity | 0,58 | Current Ratio | 0,58 |
| Interest Coverage | 3,13 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 6,11 | P/B Ratio | 0,42 |
| P/S Ratio | 0,50 | PEG Ratio | -1,24 |
| EV/EBITDA | 8,63 | Dividend Yield | 0,02% |
| Market Cap | 12,81B | Enterprise Value | 28,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25,69B | 24,38B | 20,94B | 17,99B | 17,13B |
| Net Income | 2,10B | 2,66B | 2,95B | 1,55B | 1,86B |
| EPS (Diluted) | 0,24 | 0,30 | 0,34 | 0,17 | 0,20 |
| Gross Profit | 6,61B | 17,56B | 14,70B | 12,49B | 11,99B |
| Operating Income | 3,32B | 4,03B | 4,16B | 2,69B | 3,14B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 57,49B | 56,76B | 51,25B | 48,47B | 45,51B |
| Total Liabilities | 23,46B | 22,85B | 18,90B | 19,31B | 18,23B |
| Shareholders' Equity | 30,24B | 30,14B | 29,11B | 26,19B | 24,58B |
| Total Debt | 17,46B | 14,78B | 10,05B | 10,83B | 10,87B |
| Cash & Equivalents | 1,59B | 1,51B | 2,36B | 1,83B | 5,02B |
| Current Assets | 6,64B | 6,87B | 6,71B | 8,28B | 8,53B |
| Current Liabilities | 11,37B | 9,58B | 7,46B | 7,26B | 6,05B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#279 of 616
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026